34 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
Here's Why Hold Strategy is Apt for Antero Midstream (AM) Stock https://www.zacks.com/stock/news/2252792/here-s-why-hold-strategy-is-apt-for-antero-midstream-am-stock?cid=CS-ZC-FT-analyst_blog|rank_focused-2252792 Apr 09, 2024 - Antero Midstream (AM) maintains a high ROIC, averaging 17% from 2020 to 2023, underscoring its effective use of capital in generating profits.
Antero Midstream (AM) Upgraded to Strong Buy: What Does It Mean for the Stock? https://www.zacks.com/stock/news/2257926/antero-midstream-am-upgraded-to-strong-buy-what-does-it-mean-for-the-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2257926 Apr 18, 2024 - Antero Midstream (AM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Phillips 66 (PSX) Gears Up for Q1 Earnings: What's in Store? https://www.zacks.com/stock/news/2260533/phillips-66-psx-gears-up-for-q1-earnings-what-s-in-store?cid=CS-ZC-FT-analyst_blog|earnings_preview-2260533 Apr 23, 2024 - Phillips 66's (PSX) first-quarter earnings are likely to have been negatively impacted by a weak performance in its refining segment.
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics https://www.zacks.com/stock/news/2261798/compared-to-estimates-amedisys-amed-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2261798 Apr 24, 2024 - The headline numbers for Amedisys (AMED) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Pages: 1234

<<<Page 4